Is Ozempic a Peptide?
Ozempic is a peptide-based medicine because its active ingredient, semaglutide, is a modified analogue of the peptide hormone GLP-1. The brand and molecule are related but not interchangeable terms.
Ozempic is a peptide-based medicine because its active ingredient, semaglutide, is a modified analogue of the peptide hormone GLP-1. The brand and molecule are related but not interchangeable terms.
“Reta peptide” usually refers to retatrutide, an investigational peptide that activates GIP, GLP-1, and glucagon receptors. Here is what that means—and what the evidence does not yet establish.